Millions live with chronic pain, but medicine has had little luck finding cures. Could a new range of painkillers give them hope at last, writes Robin McKie
Letters: The reason why the UK public biotech market is shrinking is a simple one. Successful early-stage biotech companies are being increasingly bought directly by big pharmaceutical companies
23 Mar 2011:
For the economy of Sandwich, in Kent, George Osborne's budget brings little hope for when Pfizer closes, its 2,400 jobs are lost – and its scientists leave
6 Feb 2011:
Asia used to just take low-value work from Britain. But as production chases the rising numbers of consumers there, where will new jobs come from here, asks Heather Stewart
There was generally good news for the energy companies this week but in the UK pharmaceuticals sector, the outlook was grim as Pfizer axed more than 2,000 jobs